| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| rigosertib | pi3-kinase gamma | NA | Successful target | TTD , DGIDB | MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Malignant Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.07 | phase 3 | unknown |
| rigosertib | polo-like kinase 1 | NA | Clinical trial target | TTD , DGIDB | MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Malignant Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.08 | phase 3 | unknown |
| click here to return to the previous page | ||||||||